Pharmacology Final Review – 150+ Verified Drug Classifications on Antipsychotics, Anticonvulsants, SSRIs – Pharm 2025

This complete pharmacology reference guide compiles 150+ expert-verified drugs, organized by therapeutic class and mechanism of action, making it an essential resource for students preparing for the Pharm 2025 Final Exam. Structured in rapid-fire Q&A format, the content emphasizes memorization-ready facts that aid in exam recall and clinical application. Key areas covered include: Psychiatric medications: Typical antipsychotics (e.g., chlorpromazine, haloperidol) Atypical antipsychotics (e.g., risperidone, olanzapine, clozapine) Depot formulations (e.g., haloperidol decanoate, paliperidone palmitate) and ODTs Neuromuscular Malignant Syndrome (NMS) treatments: dantrolene, lorazepam, propranolol Anticonvulsants: From first-line agents like phenytoin and valproate to newer agents like lacosamide, levetiracetam, and zonisamide Antidepressants: SSRIs (e.g., fluoxetine, escitalopram, fluvoxamine) SNRIs, TCAs, MAOIs, and other mood stabilizers (e.g., lithium, mirtazapine) NSAIDs and COX-2 inhibitors: ibuprofen, naproxen, celecoxib, etoricoxib Opioids: full and partial agonists including morphine, fentanyl, buprenorphine, methadone, tramadol Vaccine types and brands: Live (e.g., MMR, Varicella, Rotavirus) Inactivated and toxoid-based vaccines (e.g., DTaP, Hep A/B, HPV, HIB) This document is highly recommended for: Medical, nursing, and pharmacy students reviewing pharmacologic mechanisms Learners preparing for comprehensive finals, board exams (e.g., USMLE Step 1, NCLEX-RN, NAPLEX), or clinical rotations in psychiatry, neurology, and internal medicine Keywords: antipsychotics, atypical antipsychotics, depot antipsychotics, anticonvulsants, SSRIs, SNRIs, TCAs, MAOIs, lithium, mood stabilizers, NMS treatment, benzodiazepines, NSAIDs, COX-2 inhibitors, opioids, live vaccines, inactivated vaccines, toxoid vaccines, pharmacology review, drug classification, Pharm 2025